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Abstract
Background: Zinc has a wide spectrum of biological activities and its deficiency is related to
various abnormalities of cell metabolism.
Methods: Wistar male rats, at age of 4 weeks, were fed a low-zinc diet for six weeks. The levels
of bromodeoxyuridine incorporated into the prostatic DNA and the mRNA expression levels of
prostate thymidylate synthase and thymidine kinase were examined.
Result: The low-zinc diet caused a marked reduction in the body growth and organ weights,
resulted in a low hematopoiesis, hypo-albuminemia and hypocholesterolemia. Although there were
few differences in plasma biochemical markers, plasma levels of luteinizing hormone and
testosterone were reduced by the low-zinc diet. Bromodeoxyuridine-immunoreactive (S-phase)
cells and mRNA expression levels of thymidylate synthase and thymidine kinase in the prostate cells
were markedly affected by the low-zinc diet.
Conclusion: A low-zinc diet appears to reduce the body growth and organ weights including
prostate, causing low plasma levels of luteinizing hormone and testosterone and reduction in
prostate DNA replication in growing-rats.
Background
Zinc has a wide spectrum of biological activities and its
deficiency has been related to various abnormalities of
cell metabolism. Zinc is present in the cell nucleus, nucle-
olus and chromosomes, and zinc stabilizes the structure
of DNA, RNA and ribosomes [1]. More than 200 enzymes
require zinc as a functional component, and these
enzymes affect most major metabolic processes.
Thymidylate synthase (TS) and thymidine kinase (TK) is
key enzymes involved in de novo and salvage pathways of
pyrimidine metabolism, respectively. As previously
reported [2], a synthetic analogue of ethinyltestosterone
(danazol) reduced the weight of prostate with decline of
plasma levels of luteinizing hormone and testosterone,
resulting in lowering activities of prostate TS and TK, and
decreasing the number of bromodeoxyuridine (BrdU)-
immunoreactive (S-phase) cells in the rat prostate.
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Nutrition & Metabolism 2008, 5:12 http://www.nutritionandmetabolism.com/content/5/1/12In the present study, we investigated the effects of a low-
zinc diet on body growth, organ weights, hemograms and
plasma levels of biochemical markers and hormones, and
the expression levels of TS and TK mRNA and BrdU-
immunoreactive cells in the prostate of growing rats.
Methods
Animals and experimental procedures
Male rats of the Wistar strain (CLEA Japan, Tokyo, Japan),
3 weeks of age, were used. Throughout the experiment, all
rats were housed under controlled conditions (24 ± 0.5°C
and 12 hours of light from 6 A.M. to 6 P.M.). The animals
were permitted free access to normal commercial feed
(AIN-76A, Oriental Yeast, Tokyo, Japan), which was a
purified diet based on casein as a sole source of protein,
and tap water ad libitum at the animal research center of
the Kagawa Nutrition University (Saitama, Japan). All
experimental procedures conformed to the regulations
described in the Guide to the Care and Use of Laboratory
Animals of the U.S. National Institutes of Health (NIH).
At 4 weeks of age, the animals were divided into two
groups of 10 rats each, i.e. a control group and an experi-
mental group. The animals in the control and experimen-
tal groups were each fed 10 g per day of the control diet
(AIN-76A) and the low-zinc diet (F2ZnDD, Oriental
Yeast) [3], respectively, and weighed every 7 days. Five
animals out of each group were given a single intravenous
injection of bromodeoxyuridine (BrdU; 10 ml/kg body
weight, Cell proliferation kit, Amersham, RPN 20, Lot
315827A, Pack 318198, UK) into the tail vein, 2 hours
before autopsy. Each rat was bled, at the age of 10 weeks,
by cardiac puncture under deep anesthesia (1.5 g ure-
thane/kg body weight, Merck, Darmstadt, Germany), and
the spleen, liver, kidney, adrenals, testis, ventral prostate
and femur were removed and weighed. Each prostate
obtained was immediately fixed in a 10% formaldehyde
buffer solution (pH 7.2) to evaluate the S-phase cells in
the prostate. Examinations of hemograms, plasma levels
of hormones, and biochemical markers were performed
later (SRL, Inc., Tokyo, Japan).
Immunohistochemistry with BrdU in prostate
The levels of BrdU incorporated into the cellular DNA was
determined by a monoclonal anti-BrdU antibody; the
measurement proceeded according to the manufacture's
instructions. Six sections of each prostate were randomly
chosen and BrdU-immunoreactive cells were counted
among 400 cells per section. The results are expressed in
term of BrdU-immunoreactive (S-phase) cells as a per-
centage of total cells.
Prostatic thymidylate synthase and thymidine kinase 
mRNA
Thymidylate synthase (TS; EC 2.1.1.45) and thymidine
kinase (TK; EC 2.7.1.21) catalyze the formation of deox-
ythymidine monophosphate (dTMP) by the methylation
of deoxyuridine monophosphate (dUMP) with the con-
comitant conversion of N5,N10-methylenetetrahydrofolic
acid to 7,8-dihydrofolic acid via the de novo pathway and
the phosphorylation of thymidine via the salvage path-
way, respectively [4]. RT-PCR was performed for quantita-
tive analysis of TS and TK mRNA levels in the prostate.
Total RNA was extracted from each prostate sample with a
QuickPrep™ Total RNA Extraction Kit (Amersham Phar-
macia Biotech, Buckinghamshire, UK). Reverse transcrip-
tion was performed using oligo (dT) primers [0.5 ml oligo
(dT)12–18 primers (1.0 μg/ml) (GIBCO BRL, Gaithersburg,
MD, USA)] with a SUPERSCRIPT™ Preamplification Sys-
tem (GIBCO BRL) according to the supplier's instructions.
Once the cDNA copy had been created using the mRNA
template, the PCR was conducted immediately, as out-
lined below. Alternatively, the cDNA was stored at -20°C
until use. The PCR was performed with recombinant Taq
DNA polymerase (Nippon Gene, Tokyo) according to the
manufacture's instructions. The RNA (1.0 μg) was sub-
jected to RT-PCR using the primers for TS and TK cDNA
for 34 cycles (each cycle consisted of denaturing at 94°C
for 40 seconds, annealing at 55°C for 40 seconds and
extension at 72°C for 40 seconds) in a Gene Amp PCR
System 2400(Perkin Elmer, Branchburg, NJ, USA). RT-




ATGTGACCCAGGA-3'; and β-actin: 5'-AGGCCCAGAG-
CAAGAGAGGCAT-3' and 5'-CATGGCTGGGGTGTT-
GAAGGTC-3'). The levels of TS mRNA and TK mRNA
were determined by densitometry from photographs
taken with an image analyzer (AE6920-MF Densitograph,
ATTO, Tokyo), and are expressed as a ratio of the mRNA
level of β-actin as an internal standard.
Statistical analysis
All parameters were expressed as the mean ± standard
error (SEM). Statistical analyses were performed using the
unpaired t-test and one-way analysis of variance




There were no differences in mean body weight between
the two groups for 2 weeks after the start of the study, i.e.
at age 4 and 5 weeks. However, 3 weeks into the study, i.e.
at the age of 6 weeks, mean body weight in the low-zinc
diet group was less than 90% of the control value (p <Page 2 of 5
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approximately 80% (p < 0.01) (data not shown).
Organ weights
Although there was little difference in the wet weight of
the adrenals, the wet weights of the spleen, liver, kidney,
testis, ventral prostate and femur were markedly lower in
the low-zinc diet group than the control group (p < 0.01)
(data not shown).
Hemograms
Concentrations of hemoglobin (Hb) and hematocrit
(Ht), and numbers of erythrocytes (RBC), leukocytes
(WBC) and platelets (Pt) were lower in the low-zinc diet
group than the control group (p < 0.01 and 0.05) (data
not shown).
Plasma levels of biochemical markers and hormones
Although plasma levels of glucose, free fatty acid and trig-
lyceride were not affected by the low-zinc diet, plasma
level of total protein, albumin, total cholesterol and phos-
pholipid were lowered compared with the control (p <
0.01 and 0.05) (Table 1). The activities of glutamic-
oxaloacetic transaminase and lactate dehydrogenase were
altered by the low-zinc diet though the differences were
not statistically significant. Alkaline phosphatase activity
in animals fed the low-zinc diet was markedly reduced to
less than 60% of that in the controls (p < 0.01). Although
there were no differences in plasma concentrations of
sodium (Na), chloride (Cl), potassium (K), calcium (Ca)
and inorganic phosphorus (iP) between the groups, the
zinc (Zn) concentration in rats fed the low-zinc diet was
markedly reduced to less than 60% of that in the controls
(p < 0.01). There were no differences in plasma levels of
growth hormone and corticosterone between the groups.
However, plasma levels of luteinizing hormone and testo-
sterone were lowered by the low-zinc diet (p < 0.01).
In vivo BrdU labeling in prostate
Although BrdU-immunoreactive cells amounted to 3.19 ±
0.69% of the total cells in the prostate of the normal con-
trol (Fig. 1C), that percentage decreased to only 1.31 ±
0.48% in the prostate of rats fed the low-zinc diet (p <
0.05) (Fig. 1Z).
Expression levels of TS and TK mRNA in prostate
The mRNA expression levels of prostatic thymidylate syn-
thase (p < 0.05) and thymidine kinase (p < 0.01) were
markedly reduced to 50% of the normal control by the
low-zinc diet (Fig. 2).
Table 1: Plasma biochemical markers and hormones
Groups (n) Control diet (10) Low-zinc diet (10)
Total protein (g/dL) 5.55 ± 0.23 4.39 ± 0.14**
Albumin (g/dL) 3.98 ± 0.20 3.23 ± 0.10**
Glucose (mg/dL) 166 ± 13 169 ± 17
Total cholesterol (mg/dL) 65.5 ± 1.8 53.3 ± 4.8*
Phospholipid (mg/dL) 136 ± 5 106 ± 7**
Free fatty acid (mEQ/L) 735 ± 163 409 ± 31
Triglyceride (mg/dL) 57.3 ± 25.3 28.5 ± 4.7
Blood urea nitrogen (mg/dL) 11.9 ± 0.8 12.7 ± 0.7
Creatinine (mg/dL) 0.17 ± 0.01 0.17 ± 0.02
AST (GOT) (IU/L) 147 ± 19 204 ± 30
Lactate dehydrogenase (IU/L) 571 ± 188 263 ± 63
Alkaline phosphatase (IU/L) 883 ± 40 497 ± 62**
Sodium (Na) (mEQ/L) 139 ± 2 142 ± 1
Chlorine (Cl) (mEQ/L) 99.6 ± 1.9 100.5 ± 1.9
Potassium (K) (mEQ/L) 4.74 ± 0.30 3.97 ± 0.20
Calcium (Ca) (mg/dL) 9.51 ± 0.26 9.12 ± 0.30
inorg. Phosphorus (iP) (mg/dL) 4.50 ± 0.36 3.82 ± 0.25
Zinc (Zn) (mg/dL) 107.2 ± 0.8 61.8 ± 4.2**
Growth hormone (ng/mL) 7.66 ± 1.96 6.57 ± 0.90
Luteinizing hormone (ng/mL) 3.07 ± 0.55 1.37 ± 0.14**
Testosterone (ng/mL) 1.26 ± 0.16 0.31 ± 0.07**
Corticosterone (ng/mL) 427 ± 48 418 ± 43
Data are means ± SEM.
** and *Significantly different from that of the Control; p < 0.01 and 0.05, respectively.Page 3 of 5
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Zinc is required for many biological functions including
DNA synthesis, cell division, gene expression and the
activity of various enzymes in all animals. A deficiency of
zinc due to nutritional factors and several disease states is
now recognized as a disorder. The high phytate content of
cereal proteins is known to decrease the availability of
zinc, thus the prevalence of zinc-deficiency is likely to be
high in a population consuming large quantities of cereal
proteins [5]. Zinc-deficient Bangladeshi infants showed
improvements in rate of growth and a reduced incidence
of acute lower respiratory infections after zinc supplemen-
tation, which produced highly significant, positive
responses in height and weight [6]. Zinc-deficiency has
had negative effects on growth rate, food intake, specific
organ weights, hematological parameters, and serum lev-
els of zinc, copper and iron, especially in rats fed the low-
est zinc level [7].
In the present study, we investigated the effects of a low-
zinc diet on body growth, organ weights, hemograms,
plasma biochemical markers, plasma levels of hormones,
and the BrdU-incorporation and TS and TK mRNA expres-
sion into the prostate cells in growing rats. The low-zinc
diet caused a marked reduction in the body growth rate
and weights of the spleen, liver, kidney, testis, ventral
prostate and femur, along with a marked decline in the
plasma concentration of zinc (less than 60% of the con-
trol), compared with the control diet. It resulted in a low
hematopoiesis, hypoalbuminemia and hypocholestero-
lemia, thought it did not affect the plasma concentration
of glucose. Although there were few differences in plasma
biochemical markers, plasma levels of luteinizing hor-
mone and testosterone were markedly reduced by six-
week's feeding of a low-zinc diet. In prostate, BrdU-immu-
noreactive (S-phase) cells, and TS and TK mRNA expres-
sion levels were markedly affected by a zinc deficiency. TK
activity increases during G1 and early S phases of the cell
cycle and is often used as a marker of cell proliferation. TK
is not a zinc metalloenzyme, but the transcription of the
enzyme appears to be regulated by zinc availability. Zinc
appears to regulate TK mRNA through zinc-dependent
protein binding to the promoter region of the gene [8].
The decrease in TK activity occurred before a decline in
food intake or body weight, and therefore was not associ-
ated with decreased nutrient availability.
In conclusion, a low-zinc diet appears to reduce the body
growth and organ weights including prostate, causing low
plasma levels of luteinizing hormone and testosterone
and reduction in prostate DNA replication in growing-
rats.
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Expression levels of thymidylate synthase (TS: left sided) and thymidine kinase (TK: right sid d) mRNA in th  prostate of rats fed a ormal cont ol (upper bar) nd a low-zinc (lowerb r) dietsFigure 2
Expression levels of thymidylate synthase (TS: left 
sided) and thymidine kinase (TK: right sided) mRNA 
in the prostate of rats fed a normal control (upper 
bar) and a low-zinc (lower bar) diets.
In vivo BrdU labeling in the prostate of rats fed a normal con-trol (C: 2.25 ± 0.40%) and a low-zinc (Z: 0.68 ± 0.19%) dietsFigure 1
In vivo BrdU labeling in the prostate of rats fed a nor-
mal control (C: 2.25 ± 0.40%) and a low-zinc (Z: 0.68 
± 0.19%) diets. (Original magnification × 200).Page 4 of 5
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